Literature DB >> 1670789

Lymphoedema/hypercalcaemia syndrome mediated by parathyroid-hormone-related protein.

S Braude1, A Graham, D Mitchell.   

Abstract

A 24-year-old woman presented with a cryptogenic, hypercalcaemic syndrome with metastatic pulmonary calcification and leg and massive breast enlargement and bilateral chylous pleural effusions compatible with a generalised lymphatic abnormality. The patient's serum parathyroid hormone-related protein concentration was very high at a time when she was significantly hypercalcaemic, implying that the hypercalcaemia was mediated by this protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1670789     DOI: 10.1016/0140-6736(91)90802-v

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.

Authors:  A Benit; J Allard; J Rimailho; J Fauvel; G Escourrou; D Vezzosi; F Donadille; A Bennet; P Caron
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Primary hyperparathyroidism and Gougerot disease.

Authors:  Toumader Bouziane; Nadia Belmahi; Hanan El Ouahabi
Journal:  Eur J Rheumatol       Date:  2017-11-02

Review 3.  Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis.

Authors:  Lidan Zhao; Linfang Huang; Xuan Zhang
Journal:  Rheumatol Int       Date:  2016-05-02       Impact factor: 2.631

4.  An interesting case of systemic lupus erythematosus presenting with hypercalcemia: A diagnostic dilemma.

Authors:  Abdul Halim Abdul Gafor; Rizna Abdul Cader; Srijit Das; Noraidah Masir; Fadilah Abdul Wahid
Journal:  Am J Case Rep       Date:  2013-03-25

5.  Lupus Nephritis With Mild Asymptomatic Hypercalcemia in Children: A Case Report and Literature Review.

Authors:  Lingling Xu; Jun Zhang; Ronghui Pu; Zhihui Yue; Ying Mo; Xiaoyun Jiang
Journal:  Front Pediatr       Date:  2019-12-06       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.